KWALITY PHARMACEUTICALS
Back to Income Statement
|
KWALITY PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹24 Cr | ₹19 Cr | ₹120 Cr | ₹15 Cr | ₹8.32 Cr |
What is the latest Consolidated Net Profit of KWALITY PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹24 Cr |
| Mar2024 | ₹19 Cr |
| Mar2023 | ₹120 Cr |
| Mar2022 | ₹15 Cr |
| Mar2021 | ₹8.32 Cr |
How is Consolidated Net Profit of KWALITY PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹24 Cr | 22.83 | |
| Mar2024 | ₹19 Cr | -83.85 | |
| Mar2023 | ₹120 Cr | 692.23 | |
| Mar2022 | ₹15 Cr | 82.11 | |
| Mar2021 | ₹8.32 Cr | - | |
Compare Consolidated Net Profit of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹1,113.1 Cr | -1% | -2.8% | 21.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,329.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,674.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,891.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹107,292.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,184.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | -1% |
-2.8% |
21.2% |
| SENSEX | 0.2% |
-3.6% |
8.6% |
You may also like the below Video Courses